![PDF] Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions. | Semantic Scholar PDF] Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/66b1cd66c5a66439bb3847578e78918661a4df89/4-Table1-1.png)
PDF] Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions. | Semantic Scholar
![The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology](https://cdn.amegroups.cn/journals/pbpc/files/journals/1/articles/181/public/181-PB11-2702-R1.png/w300)
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology
![Dynamic change of serum CA19–9 levels in benign and malignant patients with obstructive jaundice after biliary drainage and new correction formulas | BMC Cancer | Full Text Dynamic change of serum CA19–9 levels in benign and malignant patients with obstructive jaundice after biliary drainage and new correction formulas | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-021-08204-w/MediaObjects/12885_2021_8204_Fig3_HTML.png)
Dynamic change of serum CA19–9 levels in benign and malignant patients with obstructive jaundice after biliary drainage and new correction formulas | BMC Cancer | Full Text
![The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology](https://cdn.amegroups.cn/journals/pbpc/files/journals/1/articles/181/public/181-PB15-4535-R1.png/w300)
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology
![IJMS | Free Full-Text | CA 19-9 Pancreatic Tumor Marker Fluorescence Immunosensing Detection via Immobilized Carbon Quantum Dots Conjugated Gold Nanocomposite IJMS | Free Full-Text | CA 19-9 Pancreatic Tumor Marker Fluorescence Immunosensing Detection via Immobilized Carbon Quantum Dots Conjugated Gold Nanocomposite](https://www.mdpi.com/ijms/ijms-19-01162/article_deploy/html/images/ijms-19-01162-sch003.png)
IJMS | Free Full-Text | CA 19-9 Pancreatic Tumor Marker Fluorescence Immunosensing Detection via Immobilized Carbon Quantum Dots Conjugated Gold Nanocomposite
![Cureus | Infection Masquerading as Recurrence of Pancreatic Ductal Adenocarcinoma: A Cautionary Tale | Article Cureus | Infection Masquerading as Recurrence of Pancreatic Ductal Adenocarcinoma: A Cautionary Tale | Article](https://assets.cureus.com/uploads/figure/file/239566/lightbox_f01ad5a0e51011ebb6d88595ca0a5730-lightbox_1e3852e0e27911ebaaa3eda02a2f981d-Screen-Shot-2021-07-11-at-2.50.25-PM.png)
Cureus | Infection Masquerading as Recurrence of Pancreatic Ductal Adenocarcinoma: A Cautionary Tale | Article
![Persistent elevation of Ca 19-9 and an unexpected finding. A case report | Cirugía y Cirujanos (English Edition) Persistent elevation of Ca 19-9 and an unexpected finding. A case report | Cirugía y Cirujanos (English Edition)](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S2444050717300761:gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w997EogCnBdOOD93cPFbanNdvmYPHt6bjyzOpfOlwJvwGBYc//ZwJBYMynuudQpd+r5uPgZn3Bk8bAnXmG/cZzggr8+Nhc/NIJ0RJJbkMNDWz98QaCsdYhUGqRFnAAM+isbIo1ebmdOETlhak8TUYhmbSXaCrOjF/5Gk4czEghiHsxjIwunYUS5qAabn/HLBYApGB3L2Kx9A6c27T0aVXwg7Sy47di7c+El1aVjNgygVGgQJWm7ZX82JA35r+3HjiV33cVfFGppsjlgKnqpk7V+s=)
Persistent elevation of Ca 19-9 and an unexpected finding. A case report | Cirugía y Cirujanos (English Edition)
![Frontiers | Diagnostic Significance of Serum IgG Galactosylation in CA19-9- Negative Pancreatic Carcinoma Patients Frontiers | Diagnostic Significance of Serum IgG Galactosylation in CA19-9- Negative Pancreatic Carcinoma Patients](https://www.frontiersin.org/files/Articles/412933/fonc-09-00114-HTML-r1/image_m/fonc-09-00114-g001.jpg)
Frontiers | Diagnostic Significance of Serum IgG Galactosylation in CA19-9- Negative Pancreatic Carcinoma Patients
![Serum CA 19-9 and CA 125 as a diagnostic marker in carcinoma of gallbladder Bind MK, Mishra RR, Kumar V, Misra V, Singh PA - Indian J Pathol Microbiol Serum CA 19-9 and CA 125 as a diagnostic marker in carcinoma of gallbladder Bind MK, Mishra RR, Kumar V, Misra V, Singh PA - Indian J Pathol Microbiol](https://www.ijpmonline.org/articles/2021/64/1/images/IndianJPatholMicrobiol_2021_64_1_65_306520_t2.jpg)
Serum CA 19-9 and CA 125 as a diagnostic marker in carcinoma of gallbladder Bind MK, Mishra RR, Kumar V, Misra V, Singh PA - Indian J Pathol Microbiol
![Combined Evaluation of AFP, CA15-3, CA125, CA19-9, and CEA Tumor Markers in Patients with Hepatitis B and C | Semantic Scholar Combined Evaluation of AFP, CA15-3, CA125, CA19-9, and CEA Tumor Markers in Patients with Hepatitis B and C | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c1eae23e45b321ff3fb5ebd61780eb875db8cd89/5-Table1-1.png)
Combined Evaluation of AFP, CA15-3, CA125, CA19-9, and CEA Tumor Markers in Patients with Hepatitis B and C | Semantic Scholar
Enhanced Discrimination of Malignant from Benign Pancreatic Disease by Measuring the CA 19-9 Antigen on Specific Protein Carriers | PLOS ONE
![Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)☆ - ESMO Open Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)☆ - ESMO Open](https://www.esmoopen.com/cms/asset/34e00613-e75e-43ea-b97b-f5f9021825d5/gr1.jpg)
Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)☆ - ESMO Open
![The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology](https://cdn.amegroups.cn/journals/pbpc/files/journals/1/articles/181/public/181-PB12-9315-R1.png/w300)
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology
![PDF] False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer. | Semantic Scholar PDF] False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1144a56968788915c60eb298e39fcf2d60c86823/5-Table2-1.png)